In summary, in this work we present the crystal structure of OPCML, identify new phenotypes of this potent tumor suppressor and map diverse functions to distinct protein structural domains through an understanding of structure/function relationships associated with clinically occurring cancer missense point mutations that impair OPCML’s function. Here, OPCML is linked to cancer.